4^th International Conference and Exhibition on Pharmacovigilance & Clinical Trials August 10-12, 2015 London, UK

OMICS Group organizing splendorous Pharmaceutical conferences welcomes you to attend the 4^th International Conference and Exhibition on Pharmacovigilance & Clinical Trials to be held during August 10-12, 2015 in London, UK, focuses on the advancements in pharmacovigilance, preclinical, clinical trials and risk management. The field of Pharmacovigilance & Clinical trials is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Pharmacovigilance-2015  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of is Pharmacovigilance-2015 is “Reviving Strategies for Safer Therapeutics in Healthcare System".

UK proves to be perfect location for production, research and sales of world-class pharmaceuticals. UK ranks sixth in the pharmaceutical marketing and is home for GlaxoSmithKline and AstraZeneca. A new method (developed by the industry-based Office of Health Economics (OHE)) of projecting drug spending in the UK forecasts that the total market will show annual growth rates of 3.1%-4.1% to 2015, while sales in the branded segment will increase 0.5%-1.8% a year and total generics sales will grow 10%-11% yearly over the period.
 

OMICS Group International is a pioneer and leading scientific event organizer, publishing around 500+ Open access journals and conducting over 1000+ Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 30,000 editorial board members, and 3.5 million followers to its credit.Every year Omics Group organizing Conference series all over the globe.
 

Track 1: Concept of Pharmacovigilance and its Significance and Scope:

Concept of Pharmacovigilance and its Significance and Scope to present the case for the importance of pharmacovigilance, to record its growth and potential as a significant discipline within medical science, and to describe its impact on patient welfare and public health and to know what is pharmacovigilance. In this Track we discussed about the Significance of pharmacovigilance. In Pharmacovigilance and healthcare system, we discussed on Pharmacovigilance role in healthcare system. In Pharmacovigilance legislation we know about the rules and laws to follow in Pharmacovigilance practice. The Role of pharma industries in the improvement of pharmacovigilance system is very important to maintain the safety data. Every Pharmaceutical industry executives and scientists and Professional staff in national pharmacovigilance centres must know about the Detection and evaluation of drug safety signals through manual and medical devices reporting.Pharmacovigilance also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines.World wide every year so many pharmacovigilance conferences were going on.

Track 2: Pre-Clinical and Clinical Trials:

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. In Designing of trials there are pre-clinical studies and different phases of clinical trials. In this trails they estimate the Bioassay and its types. The Data collection and quality control is the major part in Pre-Clinical and Clinical Trials. For some specific drugs there are some Alternative trials designs and models are used. Pre-Clinical and Clinical Trials are conducted as Multi center trials and monitoring basis. Each Pre-Clinical and Clinical Trials study of a drug, biological product, or medical device regulated by the FDA must be reviewed, approved, and monitored by the Regulatory authorities and ethics committee. There are several types of clinical trials like Clinical trials on drugs used in respiratory disorders. Advanced Information technology in clinical trials improves the quality of Pre-Clinical and Clinical Trials.

Track-3: Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics:

Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics Emerging technology in clinical trials track mainly deals on the clinical trials in long chronic diseases and several disorders. In This track we discussed about the Recent clinical trials on AIDS, Clinical trials on benign and malignant tumors, Clinical trials on cardiovascular diseases, Clinical trials on diabetes, Clinical trials of monoclonal and polyclonal antibodies, Clinical trials on drugs used in psychological disorders The current research mainly focus on Applications of biomarkers in clinical trials.

Track-4: Adverse Drug Reactions:

An Adverse drug reaction (ADR) is an injury caused by taking a medication. Many adverse drug reactions represent an exaggeration of the drug's therapeutic effects. In Classification of various adverse drug reactions we know about the different types of Adverse Drug Reactions and its effect. If we observe any Adverse Drug Reactions occurs, first we know about the Mechanism of adverse drug reactions. Assessing and reporting adverse drug reactions are very important to maintain drug safety systems. In this track we known about Expected and un-expected drug reactions and its reporting. Manufacturers, professionals, and consumers can report Post marketing reports on adverse effects. How we reduce the adverse drug reactions is discussed in Reduction of adverse drug reaction by nanotechnology topic.

Track-5: Pharmacokinetics and Pharmacodynamics:

Drugs may undergo, Pharmacokinetics and Pharmacodynamics and toxicity testing through animal testing. This data allows researchers to allometrically estimate a safe starting dose of the drug for clinical trials in humans. In this track mainly we focused on Advances in pharmacodynamic interactions, Drug and substance abuse, Drug-drug interactions. Also discussed about the Pharmacy Practices to maintain the Pharmacokinetics and Pharmacodynamics and its Challenges and its guidelines. There are several Challenges in compounding and dispensing practice in Pharmacokinetics and Pharmacodynamics.

Track-6: Pharmacy Practices and its Challenges:

In Pharmacy Practices and its Challenges track mainly focused on Pharmacy practice and its guidelines and Challenges in compounding and dispensing practice. Dosage regimen, drug toxicity and drug safety measures place important position in clinical research.

Track-7: Pharmacovigilance and Risk Management:

Pharmacovigilance and Risk Management plays major role in Drug industry. The new turn in Drug industry is to use Information technology in pharmacovigilance companies. Drug industry need to promoting companies in pharmacovigilance practice and the Review of softwares used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in risk management. In this conferences so many experts from different pharmacovigilance CRO's ,pharmacovigilance service providers were participates and shares their knowledge and discusses about the new updates. In this year there is a International conference on Pharmacovigilance-2015, which is held in London on August 10-12.

Track-8: Clinical Research and Statistics:

In Clinical Research Statistics plays major role. Depends upon the Statistics the clinical trials go for regulatory submissions. There are several guidelines mainly ICH guidelines for clinical research and its statistics follow for the clinical research. Stastical analysis of past pharmacovigilance and adverse drug reactions reports also consider for the regulatory submission.

Track-9: Strategies for Growth in Pharma Environment:

Strategies for Growth in Pharma Environment track mainly focused in Strategic development towards FDA approval and Post market product surveillances. The updates and advances in pharmacovigilance regulation system are discussed in Advances in changing pharmacovigilance regulation system track.

Track-10: Good Pharmacovigilance Practice and Pharmacoepidemiology:

Role of pharmacovigilance and pharmacoepidemiology in risk management mainly deals to avoid the insufficient evidence of safety from clinical trials. To maintain the Good reporting practices avoid major problems in risk management. Also it is important to concentrate on Signal investigation via observational studies and Interpreting safety signals. Concentrate on dosages forms in Randomized clinical trials is very important.The pharmacovigilance clinical trails services provided companies should have the Pharmacovigilance certification .

Track-11: Case Report in Clinical Trials:

Case Report in Clinical Trials plays major role in clinical research. In this track we discussed about the several case reports like Cancer case reports, Cardiovascular trials case report, Case studies on sexually transmitted diseases, Case studies on type 1 and type 2 diabetes, Case reports on drugs used in pregnancy and lactation.

Track-12: Clinical Pharmacology and Biopharmaceutics:

In Clinical Pharmacology and Biopharmaceutics track we discussed about the Rational drug management of cancer, diabetes and cardiovascular disorders, and Management of psychiatric disorders and autoimmune disorders. Along with clinical trials Bioavailability and bioequivalence studies also plays major role in clinical research.